July 8, 2020 / 11:40 AM / a month ago

BRIEF-Palatin Technologies Announces Reinitiation Of Enrollment Of Phase 2 Study With Pl9643 For Treatment Of Dry Eye Disease

July 8 (Reuters) - Palatin Technologies Inc:

* PALATIN TECHNOLOGIES, INC. ANNOUNCES REINITIATION OF ENROLLMENT OF PHASE 2 STUDY WITH PL9643 FOR THE TREATMENT OF DRY EYE DISEASE

* PALATIN TECHNOLOGIES INC - DATA READOUT TARGETED FOR Q4 OF CALENDAR YEAR 2020

* PALATIN TECHNOLOGIES - PATIENT ENROLLMENT FOR PL9643 PHASE 2 CLINICAL STUDY IS CURRENTLY EXPECTED TO BE COMPLETE WITHIN NEXT 30-45 DAYS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below